hydrochlorothiazide has been researched along with Acquired Nephrogenic Diabetes Insipidus in 21 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of acute interstitial nephritis with associated nephrogenic diabetes insipidus in a patient treated with temozolomide and sulfamethoxazole-trimethoprim for glioblastoma multiforme." | 8.02 | Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide. ( Athavale, A; Gallagher, M; Jardine, M; Morris, J; Ritchie, A; Sen, S; Wang, AY, 2021) |
| "We report a case of acute interstitial nephritis with associated nephrogenic diabetes insipidus in a patient treated with temozolomide and sulfamethoxazole-trimethoprim for glioblastoma multiforme." | 4.02 | Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide. ( Athavale, A; Gallagher, M; Jardine, M; Morris, J; Ritchie, A; Sen, S; Wang, AY, 2021) |
| " We report a case of congenital nephrogenic diabetes insipidus that was complicated by paradoxical water intoxication secondary to liberal water intake and the initiation of hydrochlorothiazide and indomethacin combination therapy." | 3.75 | Nephrogenic diabetes insipidus: treat with caution. ( Boussemart, T; Champion, G; Martin-Coignard, D; Nsota, J, 2009) |
| "Congenital nephrogenic diabetes insipidus (NDI) is a rare inherited disorder, mostly caused by AVPR2 mutations." | 1.40 | Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy. ( Deeb, A; Deekajorndech, T; Hassan, Y; Rugpolmuang, R; Sahakitrungruang, T; Shotelersuk, V, 2014) |
| "Lithium is the most common cause of nephrogenic diabetes insipidus (Li-NDI)." | 1.40 | Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter. ( Baumgarten, R; de Groot, T; Deen, PM; Devuyst, O; Kortenoeven, ML; Loffing, J; Sinke, AP; Wetzels, JF, 2014) |
| "He had been diagnosed clinically with nephrogenic diabetes insipidus and treated by amiloride and hydrochlorothiazide combination without a satisfactory outcome at another center since 1 year of age." | 1.33 | Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus. ( Hoefsloot, L; Kasap, B; Kavukçu, S; Oğün, N; Oztürk, Y; Soylu, A; Türkmen, M, 2005) |
| "Hereditary nephrogenic diabetes insipidus is a rare disease." | 1.33 | [Nephrogenic diabetes insipidus in a large family]. ( Jankauskiene, A; Kaltenis, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, D | 1 |
| Dai, Y | 1 |
| Xu, X | 1 |
| Athavale, A | 1 |
| Morris, J | 1 |
| Jardine, M | 1 |
| Gallagher, M | 1 |
| Sen, S | 1 |
| Ritchie, A | 1 |
| Wang, AY | 1 |
| Yu, Y | 1 |
| Chen, A | 1 |
| Zheng, J | 1 |
| Chen, L | 1 |
| Du, L | 1 |
| Gala-Błądzińska, A | 1 |
| Mrozek, A | 1 |
| Kędzior, A | 1 |
| Mazur, A | 1 |
| Darmochwał-Kolarz, D | 1 |
| Rugpolmuang, R | 1 |
| Deeb, A | 1 |
| Hassan, Y | 1 |
| Deekajorndech, T | 1 |
| Shotelersuk, V | 1 |
| Sahakitrungruang, T | 1 |
| Caletti, MG | 1 |
| Balestracci, A | 1 |
| Di Pinto, D | 1 |
| Sinke, AP | 1 |
| Kortenoeven, ML | 1 |
| de Groot, T | 1 |
| Baumgarten, R | 1 |
| Devuyst, O | 1 |
| Wetzels, JF | 1 |
| Loffing, J | 1 |
| Deen, PM | 1 |
| Schreuder, MF | 1 |
| Koster-Kamphuis, L | 1 |
| Boussemart, T | 1 |
| Nsota, J | 1 |
| Martin-Coignard, D | 1 |
| Champion, G | 1 |
| Pattaragarn, A | 1 |
| Alon, US | 1 |
| Vandermarliere, A | 1 |
| Maes, B | 1 |
| Vanrenterghem, Y | 1 |
| Konoshita, T | 1 |
| Kuroda, M | 1 |
| Kawane, T | 1 |
| Koni, I | 1 |
| Miyamori, I | 1 |
| Tofuku, Y | 1 |
| Mabuchi, H | 1 |
| Takeda, R | 1 |
| Kim, GH | 1 |
| Lee, JW | 1 |
| Oh, YK | 1 |
| Chang, HR | 1 |
| Joo, KW | 1 |
| Na, KY | 1 |
| Earm, JH | 1 |
| Knepper, MA | 1 |
| Han, JS | 1 |
| Soylu, A | 1 |
| Kasap, B | 1 |
| Oğün, N | 1 |
| Oztürk, Y | 1 |
| Türkmen, M | 1 |
| Hoefsloot, L | 1 |
| Kavukçu, S | 1 |
| Zaki, M | 1 |
| Schöneberg, T | 1 |
| Al Ajrawi, T | 1 |
| Al Said, AN | 1 |
| Sangkuhl, K | 1 |
| Römpler, H | 1 |
| Kaltenis, P | 1 |
| Jankauskiene, A | 1 |
| Stevens, S | 1 |
| Brown, BD | 1 |
| McGahan, JP | 1 |
| Hochberg, Z | 1 |
| Even, L | 1 |
| Danon, A | 1 |
| Takemura, N | 1 |
| Kirchlechner, V | 1 |
| Koller, DY | 1 |
| Seidl, R | 1 |
| Waldhauser, F | 1 |
| Ohta, M | 1 |
| Sahata, T | 1 |
| Mori, T | 1 |
| Takeuchi, K | 1 |
| Sugawara, A | 1 |
| Arima, S | 1 |
| Kikuya, M | 1 |
| Ito, S | 1 |
| Kimura, T | 1 |
| Ota, K | 1 |
21 other studies available for hydrochlorothiazide and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Identification of a novel X-linked arginine-vasopressin receptor 2 mutation in nephrogenic diabetes insipidus: Case report and pedigree analysis.
Topics: Asian People; Diabetes Insipidus, Nephrogenic; Humans; Hydrochlorothiazide; Indomethacin; Receptors, | 2019 |
Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Diab | 2021 |
[Analysis of AVPR2 variant in a neonate with congenital nephrogenic diabetes insipidus].
Topics: Adult; Diabetes Insipidus, Nephrogenic; Exons; Female; Frameshift Mutation; Humans; Hydrochlorothiaz | 2020 |
Treatment of congenital nephrogenic diabetes insipidus in pregnancy.
Topics: Diabetes Insipidus, Nephrogenic; Diuretics; Female; Humans; Hydrochlorothiazide; Magnesium; Potassiu | 2018 |
Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy.
Topics: Amiloride; Aquaporin 2; Child, Preschool; Diabetes Insipidus, Nephrogenic; Female; Fluid Therapy; Hu | 2014 |
Pre- and post-treatment urinary tract findings in children with nephrogenic diabetes insipidus.
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Combined Modality Thera | 2014 |
Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
Topics: Amiloride; Animals; Aquaporin 2; Cells, Cultured; Diabetes Insipidus, Nephrogenic; Epithelial Sodium | 2014 |
Poiseuille's law in polyuria.
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Insipidus, Nephrogenic; Diuretics; Huma | 2014 |
Nephrogenic diabetes insipidus: treat with caution.
Topics: Amiloride; Combined Modality Therapy; Cyclooxygenase Inhibitors; Diabetes Insipidus, Nephrogenic; Di | 2009 |
Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.
Topics: Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diabetes Insipidus, Nephro | 2003 |
Recessive type of nephrogenic diabetes insipidus.
Topics: Adult; Amiloride; Diabetes Insipidus, Nephrogenic; Diuretics; Drug Combinations; Female; Humans; Hyd | 2003 |
Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient.
Topics: Adult; Amiloride; Diabetes Insipidus, Nephrogenic; Diuretics; Drug Therapy, Combination; Humans; Hyd | 2004 |
Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.
Topics: Animals; Aquaporin 2; Aquaporins; Diabetes Insipidus, Nephrogenic; Diuresis; Drug Administration Sch | 2004 |
Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.
Topics: Amiloride; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Insipidus, Nephrogenic; Diuretics | 2005 |
Nephrogenic diabetes insipidus, thiazide treatment and renal cell carcinoma.
Topics: Amino Acid Sequence; Aquaporin 2; Carcinoma, Renal Cell; Cardiovascular Agents; Diabetes Insipidus, | 2006 |
[Nephrogenic diabetes insipidus in a large family].
Topics: Adolescent; Child; Child, Preschool; Chromosomes, Human, X; Diabetes Insipidus, Nephrogenic; Diureti | 2006 |
Nephrogenic diabetes insipidus: a cause of severe nonobstructive urinary tract dilatation.
Topics: Adolescent; Diabetes Insipidus, Nephrogenic; Dilatation, Pathologic; Diuretics; Humans; Hydrochlorot | 1995 |
Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aquaporin 2; Aquaporin | 1998 |
Successful long-term treatment of congenital nephrogenic diabetes insipidus in a dog.
Topics: Animals; Diabetes Insipidus, Nephrogenic; Diuretics; Dog Diseases; Dogs; Drinking; Hydrochlorothiazi | 1998 |
Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
Topics: Amiloride; Child Development; Child, Preschool; Diabetes Insipidus, Nephrogenic; Diuretics; Drug The | 1999 |
[The effect of hydrochrolothiazide on the patient of nephrogenic diabetes insipidus].
Topics: Adult; Diabetes Insipidus, Nephrogenic; Diuretics; Humans; Hydrochlorothiazide; Male; Sodium Chlorid | 2000 |